Cerebrospinal fluid concentrations of cefiderocol during the treatment of extensively drug-resistant Pseudomonas aeruginosa ventriculitis

被引：13
|
作者：
Luque-Paz, David [1 ,2 ]
Bennis, Youssef [3 ]
Jaubert, Paul [1 ]
Dubee, Vincent [4 ]
Wolff, Michel [5 ]
Mortaza, Satar [1 ]
机构：
[1] Univ Angers, Univ Hosp Angers, Med ICU, Angers, France
[2] Univ Hosp Rennes, Pontchaillou Hosp, Infect Dis & Intens Care Unit, Rennes, France
[3] Amiens Univ, Med Ctr, Dept Clin Pharmacol, Amiens, France
[4] Univ Hosp Angers, Dept Infect Dis, Angers, France
[5] St Anne Hosp, GHU Paris Psychiat & Neurosci, Neurosurg Intens Care Unit, Paris, France
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2022年 / 77卷 / 06期
关键词：
SOCIETY;
D O I：
10.1093/jac/dkac066
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：1787 / 1789
页数：3
相关论文
共 50 条
  • [1] Cefiderocol and Intraventricular Colistin for Ventriculitis due to an Extensively Drug-Resistant Pseudomonas Aeruginosa
    Silva, Joao Melo e
    Oliveira, Diogo
    Louro, Joao A.
    Monteiro, Elisabete
    [J]. JOURNAL OF CRITICAL CARE MEDICINE, 2024, 10 (02): : 183 - 187
  • [2] Bone and Skin/Subcutaneous Tissue Concentrations of Cefiderocol During Treatment of Extensively Drug-Resistant Pseudomonas aeruginosa
    Mueller, Scott W.
    Molina, Kyle C.
    Blass, Brittany
    Gibson, Cameron
    Kohler, Amber D.
    Krsak, Martin
    Wiktor, Arek J.
    [J]. JOURNAL OF BURN CARE & RESEARCH, 2024, 45 (03): : 808 - 810
  • [3] Plasmatic and CSF concentrations of cefiderocol in an infant with extensively drug-resistant Pseudomonas aeruginosa meningoencephalitis
    Funiciello, Elisa
    Mula, Jacopo
    Mignone, Federica
    Silvestro, Erika
    Ragazzi, Paola
    Pilloni, Giulia
    Costa, Cristina
    D'Avolio, Antonio
    Garazzino, Silvia
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2023, 78 (11) : 2776 - 2778
  • [4] Extensively drug-resistant Pseudomonas aeruginosa ventriculitis and meningitis treated with intrathecal colistin
    Karagoz, Gul
    Kadanali, Ayten
    Dede, Behiye
    Sahin, Omer Torun
    Comoglu, Senol
    Altug, Sevda Babacan
    Naderi, Sait
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2014, 43 (01) : 93 - 94
  • [5] Cefiderocol for treatment of an empyema due to extensively drug-resistant Pseudomonas aeruginosa: Clinical observations and susceptibility testing considerations
    Kufel, Wesley D.
    Steele, Jeffrey M.
    Riddell, Scott W.
    Jones, Zachary
    Shakeraneh, Pegah
    Endy, Timothy P.
    [J]. IDCASES, 2020, 21
  • [6] Cefiderocol as Adjunctive Treatment of Necrotizing Ventilator-associated Pneumonia Due to Extensively Drug-Resistant Pseudomonas aeruginosa
    Roy, Amanda M.
    Hodgson, MacGregor
    Brickman, Cristina
    MacDougall, Conan
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2021, 29 (02) : E111 - E113
  • [7] In Vitro Activity of Cefiderocol against Extensively Drug-Resistant Pseudomonas aeruginosa: CANWARD, 2007 to 2019
    Karlowsky, James A.
    Walkty, Andrew J.
    Baxter, Melanie R.
    Adam, Heather J.
    Lagace-Wiens, Philippe R. S.
    Schweizer, Frank
    Bay, Denice
    Lynch, Joseph P., III
    Mulvey, Michael R.
    Zhanel, George G.
    [J]. MICROBIOLOGY SPECTRUM, 2022, 10 (04):
  • [8] Epidemiology and Treatment of Multidrug-Resistant and Extensively Drug-Resistant Pseudomonas aeruginosa Infections
    Horcajada, Juan P.
    Montero, Milagro
    Oliver, Antonio
    Sorli, Luisa
    Luque, Sonia
    Gomez-Zorrilla, Silvia
    Benito, Natividad
    Grau, Santiago
    [J]. CLINICAL MICROBIOLOGY REVIEWS, 2019, 32 (04)
  • [9] Successful use of prolonged cefiderocol monotherapy for the treatment of a complex pleural abscess caused by extensively drug-resistant (XDR) Pseudomonas aeruginosa
    Brookfield, Charlotte
    Fadden, Emma
    Sweeney, Louise
    [J]. JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (05):
  • [10] An extensively drug-resistant Pseudomonas aeruginosa isolate from Myanmar
    Tun, Thanda
    Baleivanualala, Sakiusa Cabe
    Erdmann, Mareike Britta
    Gimenez, Gregory
    Aung, Htin Lin
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2024, 36 : 1 - 3
12345